IP Library Granted Patent US 8,214,022
Granted Patent B2
US 8,214,022 · App. 11/820,078 · Granted Jul 3, 2012

Hysterography and intrauterine venography catheter

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,214,022
App. No.
11/820,078
Granted
Jul 3, 2012
Kind
B2
Abstract

A single device is provided for performing hysterography and intrauterine venography having a marker that aids in positioning the device within the patient, having a bulb-tip to seal the cervix, having a bulb-tip opening to allow an image enhancing medium to be discharged from a needle and injected into the uterus to perform the hysterography, having a needle to discharge and inject an image enhancing medium into the fundal myometrium to perform the intrauterine venography, and having a needle securing mechanism to secure the needle to prevent patient injury during transcervical introduction of the device.

Claims (21)

1. A method for diagnosing uterine health, the method comprising:

inserting a device configured for performing hysterography and intrauterine venography transcervically into a uterus, the device comprising a catheter and a needle movably disposed through a lumen within the catheter, wherein a tip of the needle is fixably maintained within the lumen during the inserting step;

determining a correct depth of the device within the uterus by remote observation of at least one marker on the device with the first diagnostic tool;

discharging a first medium configured for enhancing the hysterography from a first syringe into the device and injecting the first medium into the uterus;

viewing the uterus using a first diagnostic tool for performing hysterography;

advancing the needle of the device into a fundal myometrium of the uterus;

discharging a second medium configured for enhancing the venography from a second syringe into the needle and injecting the second medium into the fundal myometrium; and

viewing the fundal myometrium using a second diagnostic tool for performing the venography.

2. The method according to claim 1 wherein about 5-10 ml of the first medium is discharged and about 10-20 ml of the second medium is discharged.

3. The method according to claim 1 further comprising discharging about 10 ml of the second medium from each of the second syringe and a third syringe of the device through the needle.

4. The method according to claim 1 wherein the first medium and the second medium are image enhancing media and are the same or different.

5. The method according to claim 1 wherein the first diagnostic tool and the second diagnostic tool are a fluoroscope, x-ray, or ultrasound, and are the same or different.

6. The method according to claim 1 further comprising sealing the cervix by using a bulb-tip of the device.

7. The method according to claim 1 wherein the first syringe and the second syringe are the same or different.

8. The method according to claim 1 further comprising a securing mechanism disposed at a proximal end portion of the catheter, wherein the securing mechanism is configured to be adjustable between a first orientation fixing the position of the needle with respect to the catheter and a second orientation allowing the needle to slide within the lumen and out of a distal end of the catheter.

9. The method according to claim 8 further comprising locking the needle with respect to the catheter with the securing mechanism prior to inserting the device into the uterus.

10. The method according to claim 9 further comprising unlocking the needle with respect to the catheter with the securing mechanism prior to advancing the needle into the fundal myometrium of the uterus.

11. The method according to claim 9 further comprising unlocking the needle with respect to the catheter with the securing mechanism after a distal end of the catheter contacts the fundal myometrium.

12. The method according to claim 1 where the at least one marker on the device comprises two markers upon a distal portion of the catheter, wherein the two markers are spaced at a fixed distance apart and are each remotely observable with the first diagnostic tool.

13. The method according to claim 12 wherein the two markers upon the distal portion of the catheter are each radiopaque or echogenic.

14. The method according to claim 12 further comprising the step of measuring aspects of the fundal myometrium based upon comparison of the relative positioning and distance of the two markers with remotely observable aspects of the fundal myometrium using the second diagnostic tool.

Assignments (6)
CHANGE OF NAME Recorded Apr 7, 2025
From: NEW US OPCO INC.
To: NEXPRING US OPCO INC.
Reel/Frame 070761/0372 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 30, 2025
From: COOK MEDICAL TECHNOLOGIES LLC
To: NEW US OPCO INC.
Reel/Frame 070070/0161 →
TERMINATION OF SECURITY INTEREST IN TRADEMARKS AND PATENTS Recorded Dec 5, 2024
From: WILMINGTON TRUST, NATIONAL ASSOCIATION
To: COOK MEDICAL TECHNOLOGIES LLC
Reel/Frame 069516/0799 →
SECURITY INTEREST Recorded Feb 28, 2024
From: COOK MEDICAL TECHNOLOGIES LLC
To: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 066700/0277 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 29, 2012
From: COOK INCORPORATED
To: COOK MEDICAL TECHNOLOGIES LLC
Reel/Frame 027783/0529 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 9, 2008
From: PERRY, C. PAUL; MARVEL, RICHARD P.; BILTZ, BENJAMIN T.; BOSLEY, RODNEY W., JR.; MILLER, JESSICA WATTS; WINGLER, TROY W.
To: VANCE PRODUCTS INCORPORATED, D/B/A COOK UROLOGICAL INCORPORATED
Reel/Frame 020343/0053 →